HR_D

(VRTX) Vertex - Upside potential ahead of Earnings release

Long
HR_D Updated   
NASDAQ:VRTX   Vertex Pharmaceuticals Incorporated
Vertex is now at levels close to those of Dec'19. Meanwhile, revenues increased +60% QoQ for Q3 2020 and EPS increased + 20% (also QoQ for Q3 2020). Operational cashflows have improved as well. If expected annual earnings are confirmed, Vertex confirms its upside potential and has also a positive outlook ahead as a result of the current environment.
Trade closed: stop reached:
Thanks for your thumbs up on the idea. The stock hit my stop loss and thus I am out for the moment. VRTX reported Q4'2020 EPS of $2.51, missing the of $2.65 target - this is leading a downward drift. As pointed before, my thesis was yet to be confirmed by earnings release. Despite all this, earnings rose 47.6% YoY for VRTX. Thus, I still believe this is a great company to invest but I cannot see at which point it will (potentially) revert. Im waiting to enter again at a better stage (maybe 197-202 range?).
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.